WR's own website states that there are no FDA approved therapies for the early treatment of TBI's. TBI is second only to haemorrhage on the scale of in service trauma for US military. NYR have got a developmental therapy for TBI on the radar of WR for $150k! What's not to like? The talk of 10yrs for approval? The same or quicker than your average Mine, but speculation and SP growth comes way before production if potential is realised and demonstrated. IMO
NYR Price at posting:
4.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)